The iNOS protein positive expression rates were 72.1% (31/43), 28.2% (11/39), and 3.1% (2/33) in the cervical cancer group, HR-HPV group, and control group, respectively (P < 0.05). The gene discussed is NOS2; the disease is cervical carcinoma.